LAZZERINI, PIETRO ENEA
 Distribuzione geografica
Continente #
NA - Nord America 7.114
EU - Europa 6.065
AS - Asia 1.005
OC - Oceania 14
SA - Sud America 13
Continente sconosciuto - Info sul continente non disponibili 8
AF - Africa 6
AN - Antartide 1
Totale 14.226
Nazione #
US - Stati Uniti d'America 7.090
GB - Regno Unito 1.731
IE - Irlanda 1.159
CN - Cina 766
IT - Italia 754
SE - Svezia 697
DE - Germania 561
UA - Ucraina 527
FR - Francia 312
FI - Finlandia 159
VN - Vietnam 125
ES - Italia 44
RU - Federazione Russa 39
IN - India 38
BE - Belgio 31
TR - Turchia 29
CA - Canada 20
GR - Grecia 17
TH - Thailandia 17
NL - Olanda 13
AU - Australia 11
EU - Europa 7
IR - Iran 6
BR - Brasile 5
IL - Israele 5
HK - Hong Kong 4
PL - Polonia 4
CL - Cile 3
HR - Croazia 3
NZ - Nuova Zelanda 3
RO - Romania 3
SG - Singapore 3
DK - Danimarca 2
EG - Egitto 2
ID - Indonesia 2
KR - Corea 2
MY - Malesia 2
PE - Perù 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AR - Argentina 1
BG - Bulgaria 1
BY - Bielorussia 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
EE - Estonia 1
FK - Isole Falkland (Malvinas) 1
GS - Georgia del Sud e Isole Sandwich Australi 1
HU - Ungheria 1
IQ - Iraq 1
JM - Giamaica 1
JP - Giappone 1
KE - Kenya 1
KG - Kirghizistan 1
KZ - Kazakistan 1
MA - Marocco 1
MX - Messico 1
NG - Nigeria 1
PA - Panama 1
RS - Serbia 1
ZA - Sudafrica 1
Totale 14.226
Città #
Southend 1.606
Fairfield 1.169
Dublin 1.127
Ashburn 632
Chandler 599
Woodbridge 543
Houston 445
Jacksonville 424
Wilmington 420
Seattle 416
Cambridge 394
Menlo Park 308
Ann Arbor 291
Siena 287
Princeton 209
Beijing 199
Nanjing 155
Dong Ket 125
Dearborn 93
Helsinki 81
Vimercate 78
San Diego 74
New York 69
Boardman 65
San Mateo 64
Nanchang 59
Florence 46
Shanghai 41
Shenyang 41
Málaga 40
Brussels 31
Hebei 27
Lancaster 26
Milan 26
Izmir 24
London 24
Tianjin 23
Kunming 21
Norwalk 21
Jinan 20
Jiaxing 19
Changsha 18
Toronto 18
Fremont 17
Hefei 17
Falls Church 16
Pune 16
San Francisco 16
Guangzhou 15
Venezia 15
Düsseldorf 14
Ningbo 14
Washington 14
Mestre 13
Zhengzhou 12
Redwood City 11
Caserta 10
Lappeenranta 10
Hangzhou 9
Taizhou 9
Changchun 8
Los Angeles 8
Rome 8
Nicola 7
Phoenix 7
Sacramento 7
Aulla 6
Canberra 6
Fuzhou 6
Hounslow 6
Paris 6
Tappahannock 6
Lanzhou 5
Petah Tikva 5
Prato 5
Turin 5
Anguillara Sabazia 4
Arezzo 4
Grosseto 4
Livorno 4
Modena 4
Queens 4
Sinalunga 4
Amsterdam 3
Athens 3
Auburn Hills 3
Campi Bisenzio 3
Canzo 3
Chicago 3
Chongqing 3
Clearwater 3
Cuneo 3
Esslingen am Neckar 3
Frankfurt am Main 3
Kilburn 3
Kolkata 3
Leawood 3
Pisa 3
San Giovanni Valdarno 3
Sesto Fiorentino 3
Totale 10.806
Nome #
Systemic inflammation as a novel QT-prolonging risk factor in patients with torsades de pointes 274
Marked QTc Prolongation and Torsades de pointes in Patients with Chronic Inflammatory Arthritis 238
Searching Novel Therapeutic Targets for Scleroderma: P2X7-Receptor Is Up-regulated and Promotes a Fibrogenic Phenotype in Systemic Sclerosis Fibroblasts 231
Arrhythmogenicity of Anti-Ro/SSA antibodies in patients with torsades de pointes 224
P wave dispersion in cryptogenic stroke: A risk factor for cardioembolism? 222
Proton pump inhibitors and serum magnesium levels in patients with Torsades de Pointes 222
Adenosine A2A receptor activation stimulates collagen production in sclerodermic dermal fibroblasts either directly and through a cross-talk with the cannabinoid system 219
Association between high sensitivity C-reactive protein, heart rate variability and corrected QT interval in patients with chronic inflammatory arthritis. 209
The purinergic P2×7 receptor is expressed on monocytes in Behçet's disease and is modulated by TNF-α 203
Antiarrhythmic potential of anti-cytokine therapy in rheumatoid arthritis: Tocilizumab reduces QTc interval by controlling systemic inflammation. 198
Non-HCV-related cryoglobulinemic vasculitis and parvovirus-B19 infection 196
Torsades de Pointes in patients with polymyalgia rheumatica 195
Spotlight on sirukumab for the treatment of rheumatoid arthritis: The evidence to date 188
Antirheumatic agents in covid-19: is IL-6 the right target? 180
Levels of circulating CXCR4-positive cells are decreased and negatively correlated with risk factors in cardiac transplant recipients 173
Adenosine receptors expression in cardiac fibroblasts of patients with left ventricular dysfunction due to valvular disease 172
Systemic Inflammation Rapidly Induces Reversible Atrial Electrical Remodeling: The Role of Interleukin-6–Mediated Changes in Connexin Expression 170
Synthetic cannabinoid ajulemic acid exerts potent antifibrotic effects in experimental models of systemic sclerosis 169
Induction of autoimmune response to the extracellular loop of the HERG channel pore induces QTc prolongation in guinea-pigs 167
Anti-Ro/SSA-associated corrected QT interval prolongation in adults: the role of antibody level and specificity 162
Connective tissue diseases and cardiac rhythm disorders: an overview 156
Statins and the joint: multiple targets for a global protection? 156
Isolated atrioventricular block of unknown origin in the adult and autoimmunity: Diagnostic and therapeutic considerations exemplified by 3 anti-Ro/SSA-associated cases 155
Assessing QT interval in patients with autoimmune chronic inflammatory diseases: perils and pitfalls 153
How to Identify Patients at Risk of Silent Atrial Fibrillation after Cryptogenic Stroke: Potential Role of P Wave Dispersion 150
Isolated atrioventricular block of unknown origin in adults and anti-Ro/SSA antibodies: Clinical evidence, putative mechanisms, and therapeutic implications 147
Prolongation of the corrected QT interval in adult patients with anti-Ro/SSA positive connective tissue diseases 146
The role of P2X7 receptors in tissue fibrosis: a brief review 146
Comparison of frequency of complex ventricular arrhythmias in patients with positive versus negative anti-Ro/SSA and connective tissue disease 145
Cyclosporin and tacrolimus increase plasma levels of adenosine in kidney transplanted patients 145
Simvastatin inhibits T cell activation by selectively impairing the function of RAS superfamily GTPases. 144
Increased arterial stiffness is an independent risk factor for hemorrhagic transformation in ischemic stroke undergoing thrombolysis 144
Previous use of statins and atrial electrical remodeling in patients with cryptogenic stroke 144
Early and delayed increase in plasma homocysteine levels in heart transplanted patients. 143
Autoimmune and inflammatory K+ channelopathies in cardiac arrhythmias: Clinical evidence and molecular mechanisms 143
Rosuvastatin inhibits spontaneous and IL-1β-induced interleukin-6 production from human cultured osteoblastic cells. 142
null 141
Pravastatin treatment-associated reduction in plasma homocysteine in heart-transplanted patients. 140
Changes of peripheral A2A adenosine receptors in chronic heart failure and cardiac transplantation 139
T lymphocytes as targets of statins: molecular mechanisms and therapeutic perspectives. 139
The "Invulnerability" of the Adult Conduction System to Anti-Ro/SSA Antibodies? A Matter of Calcium Channel Expression on the Cardiomyocyte 138
Systemic inflammation and arrhythmic risk: lessons from rheumatoid arthritis 135
Biologic drugs and arrhythmic risk in chronic inflammatory arthritis: the good and the bad 134
Inflammatory cytokines, life-threatening arrhythmias and premature mortality in chronic inflammatory arthritis: Time to focus on 134
Autoimmune channelopathies as a novel mechanism in cardiac arrhythmias 133
Correlation between cardiac oxidative stress and myocardial pathology due to acute and chronic norepinephrine administration in rats. 132
Autoantibody-mediated cardiac arrhythmias: mechanisms and clinical implications 130
Arrhythmic risk in rheumatoid arthritis: the driving role of systemic inflammation. 130
Reduction in plasma homocysteine level in patients with rheumatoid arthritis given pulsed glucocorticoid treatment. 128
Autoimmune Calcium Channelopathies and Cardiac Electrical Abnormalities 128
The effects of age and hyperhomocysteinemia on the redox forms of plasma thiols 126
null 126
Homocysteine and Raynaud’s phenomenon: a review. 126
null 124
Cardiac dysautonomia in patients with superior vena cava syndrome due to compression by lung cancer. 122
Psychosine-induced apoptosis and cytokine activation in immune peripheral cells of Krabbe patients. 122
null 122
null 122
Acute effects of glibenclamide on reactive hyperaemia in the lower limbs in humans. 119
Cardioimmunology of arrhythmias: the role of autoimmune and inflammatory cardiac channelopathies 118
Statins as a new therapeutic perspective in myocarditis and postmyocarditis dilated cardiomyopathy 117
Combination Therapy With Ceftriaxone and Lansoprazole, Acquired Long QT Syndrome, and Torsades de Pointes Risk 116
Anti-Ro/SSA antibodies and cardiac arrhythmias in the adult: facts and hypotheses 115
Atrial cardiopathy and sympatho-vagal imbalance in cryptogenic stroke: Pathogenic mechanisms and effects on electrocardiographic markers 115
Human rheumatoid synoviocytes express functional P2X7 receptors 114
Corrected QT interval in anti-SSA-positive adults with connective tissue disease: Comment on the article by Lazzerini et al. [6] (multiple letters) 114
Comment on: Letter to the Editor from Clockaerts and Bierma-Zeinstra. 113
Potassium Channel Block and Novel Autoimmune-Associated Long QT Syndrome 113
Cannabinoids inhibit fibrogenesis in diffuse systemic sclerosis fibroblasts. 112
Pathogenesis of the novel autoimmune-associated long-QT syndrome 112
Emerging arrhythmic risk of autoimmune and inflammatory cardiac channelopathies 112
Androgen Deprivation Therapy for Prostatic Cancer in Patients With Torsades de Pointes 112
Cardiac Arrest Risk during Acute Infections: Systemic Inflammation Directly Prolongs QTc Interval via Cytokine-Mediated Effects on Potassium Channel Expression 109
Oral low-dose dipyridamole protects from intravenous high-dose dipyridamole-induced ischemia. A oral echocardiographic study 108
Interleukin-6 inhibition of hERG underlies risk for acquired long QT in cardiac and systemic inflammation 108
Long QT Syndrome: An Emerging Role for Inflammation and Immunity 107
Photopheresis immunomodulation after heart transplantation. 106
null 105
Proton pump inhibitors directly block hERG-potassium channel and independently increase the risk of QTc prolongation in a large cohort of US Veterans 105
Simvastatin reduces MMP-3 level in interleukin 1b-stimulated human chondrocyte culture 104
Arrhythmic risk during acute infusion of infliximab: a prospective, single-blind, placebo-controlled, cross-over study in patients with chronic arthritis 103
Homocysteine and P wave dispersion in patients with heart transplantation 101
Hyperhomocysteinemia: a cardiovascular risk factor in autoimmunediseases? 99
Arrhythmogenic effects of anti-Ro/SSA antibodies on theadult heart: more than expected? 96
Simvastatin inhibits cytokine production and nuclear factor-kB activation in interleukin 1beta-stimulated synoviocytes from rheumatoid arthritis patients 95
Hyperhomocysteinemia, inflammation and autoimmunity 91
Le indicazioni al trattamento con immunoglobuline endovena nelle malattie reumatiche. [Indications for intra-venous immunoglobulin treatment in rheumatic diseases] 91
Inhibitory effect of synthetic cannabinoids on cytokine production in rheumatoid fibroblast-like synoviocytes 91
Alteration in the redox state of plasma in heart transplanted patients with moderate hyperhomocisteinemia 90
Effects of acute administration of iloprost on the cardiac autonomic nervous system and ventricular repolarisation in patients with systemic sclerosis 89
P wave dispersion and silent atrial fibrillation in cryptogenic stroke: The pathogenic role of inflammation 87
Blunted increase in plasma adenosine levels following dipyridamole stress test in dilated cardiomyopathy patients 85
Comment on “Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) vaccine: Causality or casualty?” 84
Electrocardiographic Predictors of Silent Atrial Fibrillation in Cryptogenic Stroke 78
Commentary: Systemic effects of IL-17 in inflammatory arthritis 76
Neutrophil extracellular traps release in gout and pseudogout depends on the number of crystals regardless of leukocyte count 73
Upregulation of A2A adenosine receptor expression by TNFa in PBMC of patients with CHF: a regulatory mechanism of inflammation. 71
Anti-Ro/SSA Antibodies Blocking Calcium Channels as a Potentially Reversible Cause of Atrioventricular Block in Adults 69
null 68
Risk of qtc interval prolongation associated with circulating anti-ro/ssa antibodies among us veterans: An observational cohort study 66
Totale 13.399
Categoria #
all - tutte 43.528
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.528


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019776 0 0 0 0 0 0 0 0 0 0 402 374
2019/20203.109 325 118 178 444 191 316 341 389 254 265 114 174
2020/20212.517 127 216 96 258 123 284 168 301 300 220 208 216
2021/20221.894 135 220 91 146 130 55 91 146 142 167 196 375
2022/20232.267 144 244 310 318 179 435 78 160 228 65 60 46
2023/20241.719 69 39 149 96 94 531 604 60 32 45 0 0
Totale 14.505